| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.082 | 0.07 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.07 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.096 | 0.08 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.084 | 0.08 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.054 | 0.08 |